Distribution of patients with 2,8-dihydroxyadenine urolithiasis and adenine phosphoribosyltransferase deficiency in Japan.
2,8-Dihydroxyadenine urolithiasis is caused by genetic deficiencies of adenine phosphoribosyl-transferase. This disease has occurred in a large number of Japanese patients and more than half of all families with this disease are only partially deficient in enzyme activities (Japanese type adenine phosphoribosyltransferase deficiency). To clarify the reasons for the preponderance of Japanese cases we sent questionnaires to 948 Japanese urological departments. The data thus obtained indicated that 76 families had 2,8-dihydroxyadenine lithiasis and of 51 families in which adenine phosphoribosyltransferase activities were assayed 76 per cent were only partially deficient in adenine phosphoribosyltransferase activities. The distribution of the 2,8-dihydroxyadenine families was roughly similar to that of the population in Japan and the rates of the Japanese type adenine phosphoribosyltransferase deficiency families were not significantly different among the various parts of Japan. These data indicate that the wide distribution of the unique mutant gene, APRT*J, that was created many years ago in a Japanese ancestor, explains at least in part the large number of 2,8-dihydroxyadenine lithiasis and adenine phosphoribosyltransferase deficiency families among the Japanese.